Old Web
English
Sign In
Acemap
>
authorDetail
>
A. M. C. Dingemans
A. M. C. Dingemans
Medicine
Pemetrexed
non-small cell lung cancer (NSCLC)
Carboplatin
Clinical endpoint
2
Papers
8
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
3 Casus 7 Een patiënt met longkanker en dyspneu, hoesten en hemoptoë
2010
E.F. Smit
A. M. C. Dingemans
Show All
Source
Cite
Save
Citations (0)
A randomized phase II study of pemetrexed (P) versus pemetrexed-carboplatin (PC) as second line treatment for patients (pts) with advanced non-small-cell lung cancer (NSCLC)- NVALT 7
2008
Journal of Clinical Oncology
Egbert F. Smit
Harry J.M. Groen
Hans J. M. Smit
Bonne Biesma
P. Eppinga
A. M. C. Dingemans
N.C. van Walree
Andrew Vincent
N. Van Zandwijk
Show All
Source
Cite
Save
Citations (8)
1